https://www.selleckchem.com/products/BIBF1120.html
At her last follow-up visit to date, Snellen VAs were 6/9 and 3/60 in her right and left eye respectively. This is a unique case of CNV formation in a predicted choroideraemia carrier who also has co-existent high myopia. Prompt treatment of CNV activity with anti-VEGF has been efficacious in prevention of subretinal fibrosis and irreversible vision loss and allowed the patient to continue working in her chosen career. This is a unique case of CNV formation in a predicted choroideraemia carrier who also has co-existent high myopia. Pro
Curtir
Comentario
Compartilhar
